In response to ACR and provider concerns about administrative burden, CVS Caremark has issued a streamlined version of its prior authorization forms for many biologic drugs.
ACR Leaders to Meet with Members of Congress at May 12 Capitol Hill Event
The meetings will focus on legislation affecting rheumatology, including bills on graduate medical education and use of copay assistance funds.
Providers Who Received Period 1 Relief Funds May Request to Submit Late Reports
Practices that received Provider Relief Funds between April 10–June 30, 2020, and did not file a report may request to submit a late report and avoid having funds recouped.
Trends in State White Bagging Legislation
The ACR is working with partners in several states to legislate against policies that require physicians to acquire provider-administered drugs through a preferred specialty pharmacy designated by a payer or pharmacy benefit manager.
Update from the ACR Insurance Subcommittee
The ISC has worked with CVS Caremark to revisit changes to its prior authorization forms that would have increased the administrative burden on practices, and patients with Blue Cross Blue Shield of South Carolina may not have to worry about switching to a self-administered biologic.
What I Learned from My Year on the ACR’s Government Affairs Committee
As a fellow-in-training member of the ACR’s Government Affairs Committee, Kaitlyn Brittan, MD, found a sense of personal satisfaction and empowerment by having a voice through advocacy.
Dr. Lorna Breen Health Care Provider Protection Act Passed by Congress
The ACR-supported Breen Act will provide resources for mental health services and programs for healthcare professionals to reduce burnout and prevent suicide.
Partnership Amplifies Advocacy Reach
Working with the AMA provides a megaphone to amplify rheumatology’s voice at both federal and state levels. This year is the AMA’s next five-year membership review. Join the AMA or renew your membership now to keep the ACR represented in AMA policy bodies.
ACR Insurance Subcommittee Chair Encourages Member Engagement
Rheumatology practices have a voice in payer advocacy through the Insurance Subcommittee of the ACR’s Committee on Rheumatologic Care.
Defining Administration Complexity by the Drug, Not the Diagnosis
Enabling rheumatology practices to use complex administration codes for biologic drugs is critical for maintaining patient access to essential therapies.
- « Previous Page
- 1
- …
- 9
- 10
- 11
- 12
- 13
- …
- 86
- Next Page »